IREN
IREN Limited
There isn't enough reported data to score IREN yet.
UWMC
UWM Holdings Corporation
UWMC's fundamentals are mixed: revenue grew 28%, but its operating margin fell 2 points to 2.8%. At 16x earnings, it's trading about 13 times its usual 1.2x. Analysts expect earnings to fall sharply, though they disagree widely on how much.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
UWMC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| N/A | |
| N/A |
UWMC's revenue is currently healthy, and its profitability is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like UWMC.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
UWMC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 0.5x | $0.04 | -97% |
| Fair | 1.2x | $0.10 | -92% |
| Forward | 9.3x | $1.27 | — |
| Current | 16x | $1.27 | — |
| Expensive | 59x | $4.69 | +269% |
Historical ranges are pointers, not guarantees.
UWMC's PE is in its fair range at 16x. On analysts' estimates for next year's earnings, today's price would be 9.3x.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
IREN has the edge over UWMC on the outlook, with more favorable revenue and profitability expectations.
UWMC Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong decline | |
| Decline | |
| Weakening | |
| Limited | |
| Low |
Analysts expect UWMC's earnings and revenue to decline, with profitability weakening. However, they disagree widely on these estimates.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.
UWMC Earnings Per Share
UWMC and IREN do not have enough comparable growth data to identify a winner.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN's revenue has held roughly level: $228M last quarter, down 5.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
UWMC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $811.1M | -3.8% |
| Q2 2026 | $888M | +17% |
| Q1 2026 | $901.4M | +47% |
| Q4 2025 | $945.2M | +69% |
| Q3 2025 | $843.3M | +60% |
| Q2 2025 | $758.7M | +50% |
| Q1 2025 | $613.4M | +7.6% |
| Q3 2024 | $526.4M | -22% |
UWMC's revenue is growing: $811M last quarter, down 3.8% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 28% | +26 points |
| Q2 2026 | -53% | -97 points |
| Q1 2026 | 20% | +62 points |
| Q4 2025 | 18% | +10 points |
| Q3 2025 | 1.5% | -4.6 points |
| Q2 2025 | 43% | +28 points |
| Q1 2025 | -43% | -75 points |
| Q4 2024 | 7.6% | N/A |
UWMC has the edge over IREN on profitability, with a higher operating margin.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
UWMC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $14.2M | +$3.1B |
| Q2 2026 | $334.6M | +$624.6M |
| Q1 2026 | -$2.2B | -490% |
| Q4 2025 | $82M | +$633.6M |
| Q3 2025 | -$3.1B | -$899.1M |
| Q2 2025 | -$290.1M | +$1B |
| Q1 2025 | $576.1M | +$2.8B |
| Q3 2024 | -$2.2B | -745% |
UWMC has the edge over IREN on cash flow, with more consistent year-over-year improvement.
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has the edge over UWMC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
UWMC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.7% | +5.8M shares |
| 1 year | +70% | +141M shares |
UWMC has 343M diluted shares, up 70% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2022 | — |
| Q3 2022 | — |
| Q4 2021 | $60.6M |
| Q3 2021 | $15.3M |
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
UWMC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 16.2x | High |
| Q1 2026 | 3.4x | Elevated |
| Q4 2025 | 8.2x | High |
| Q3 2025 | 16.8x | High |
| Q2 2025 | 12.0x | High |
| Q4 2024 | 5.9x | High |
| Q3 2023 | 3.4x | Elevated |
| Q2 2023 | 3.4x | Elevated |
UWMC's net debt is about 16 years of its operating earnings (EBITDA), up from 12 years a year ago. Net leverage isn't a meaningful measure for financial services companies like UWMC.
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
UWMC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.7 | Neutral |
| Stochastic | 47.8 | Neutral |
UWMC's weekly RSI is 35 (neutral) and its Stochastic is 48 (neutral).
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
UWMC PE vs Financial Services Sector
| Metric | UWMC | Sector median | Relative |
|---|---|---|---|
| PE | 16x | 13x | 22% above |
| PE % | 54 | 64 | 10 pts below |
UWMC is trading at 16x earnings, a 22% premium to the Financial Services sector's median of 13x.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has the edge over UWMC on trend strength, trading above more of its moving averages.
UWMC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.30 | 2.3% below |
| 20 week MA | $1.51 | 16% below |
| 50 week MA | $3.02 | 58% below |
| 100 week MA | $4.17 | 70% below |
| 200 week MA | $5.24 | 76% below |
UWMC is in a downtrend: it's below all five of its weekly moving averages, and 76% below its 200-week average.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN has the edge over UWMC on returns for 2026, with the stronger performance.
UWMC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.30 | $12.8 | +37% |
| 2021 | $12.8 | $6.38 | -50% |
| 2022 | $6.38 | $3.56 | -44% |
| 2023 | $3.56 | $7.15 | +101% |
| 2024 | $7.15 | $5.78 | -19% |
| 2025 | $5.78 | $4.59 | -21% |
| 2026 YTD | $4.59 | $1.27 | -72% |
UWMC's yearly returns have swung widely, from +101% in 2023 to −50% in 2021. It's down 72% so far in 2026.